期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 167, 期 -, 页码 148-169出版社
ELSEVIER
DOI: 10.1016/j.addr.2020.06.029
关键词
Animal models; Inhalation; Pharmacodynamics; Pharmacokinetics; Toxicokinetics
资金
- French National Research Agency (ANR) as part of the Investissements d'Avenir program [ANR-10-LABX-53-01]
Nonclinical studies are fundamental for the development of inhaled drugs, as for any drug product, and for successful translation to clinical practice. They include in silico, in vitro, ex vivo and in vivo studies and are intended to provide a comprehensive understanding of the inhaled drug beneficial and detrimental effects. To date, animal models cannot be circumvented during drug development programs, acting as surrogates of humans to predict inhaled drug response, fate and toxicity. Herein, we review the animal models used during the different development stages of inhaled pharmaceuticals and biopharmaceuticals, highlighting their strengths and limitations. (C) 2020 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据